Established in July 2004, Laxmi Dental Limited is a comprehensive provider of dental solutions. The company specializes in delivering high-quality products such as custom crowns and bridges, innovative clear aligners, advanced thermoforming sheets, aligner-related accessories, specialized pediatric dental items, and other offerings tailored to meet the diverse needs of dental professionals.
Laxmi Dental Limited primarily focuses on the manufacturing and distribution of dental care products and equipment. The company is committed to improving dental care standards through the provision of high-quality products and is recognized for its dedication to innovation and customer satisfaction. Additionally, Laxmi Dental Limited likely engages in the wholesale and retail supply of dental products both domestically and internationally.
(January 14, 2025, 12:24:11 PM)
The Laxmi Dental IPO achieved an overall subscription of 9.41 times on January 14, 2025 (Day 2). The public issue was subscribed to 20.34 times, non-institutional investor (NII) segment at 20.65 times. Within the NII category, bids above ₹10 lakh (bNII) were subscribed 20.93 times, while bids below ₹10 lakh (sNII) saw a subscription of 20.08 times. However, the qualified institutional buyers (QIB) category was only subscribed 0.14 times.
The Laxmi Dental IPO, a book-built issue valued at ₹698.06 crores, includes a fresh issue of 0.32 crore shares amounting to ₹138.00 crores and an Offer for Sale (OFS) of 1.31 crore shares aggregating to ₹560.06 crores. The IPO subscription period runs from January 13 to January 15, 2025, with allotment finalization on January 16 and listing on January 20, 2025, on the BSE and NSE. The price band is set between ₹407 and ₹428 per share, with a minimum lot size of 33 shares per application. Retail investors require a minimum investment of ₹14,124, while small Non-Institutional Investors (sNII) need 15 lots (495 shares) worth ₹2,11,860, and big Non-Institutional Investors (bNII) require 71 lots (2,343 shares) amounting to ₹10,02,804.
Also Read : Laxmi Dental IPO Day 1 Subscription Status
The proceeds from the fresh issue will be utilized for the following purposes:
GMP Details: According to Live Mint, the latest Grey Market Premium (GMP) for the Laxmi Dental IPO stands at ₹142. With an IPO price band set at ₹428, the estimated listing price is anticipated to be ₹570, with a 33% gain over the IPO price.
Note: The Grey Market Premium (GMP) is not an official price and is based on market speculation.
Founded in January 2005, Barflex Polyfilms Limited specializes in the production of COEX films, laminates, and labels, offering flexible packaging solutions tailored to diverse industries such as FMCG, processed foods, adhesives, engineering, pharmaceuticals, cosmetics, and construction. Serving prominent domestic brands, the company manufactures a wide range of products, including 3-layer and 5-layer poly films, laminates, vacuum pouches, bulk liners, and PVC shrink labels. With plans to expand its offerings to include 7-layer films, Barflex aims to strengthen its position as a preferred packaging partner for its customers.
Barflex is known for its focus on innovation, customization, and sustainability in its packaging solutions. By catering to its clients' diverse needs, the company has built a reputation for reliability and excellence. Additionally, Barflex places a strong emphasis on maintaining strict quality control standards and ensuring timely product delivery to its customers. As part of its growth strategy, Barflex is focused on expanding its product offerings and enhancing its market presence both in India and internationally.
(January 14, 2025, 12:19:59 PM)
The Barflex Polyfilms IPO has been subscribed 6.59 times overall as of January 14, 2025 (Day 3). The retail investor category was subscribed 10.22 times, while the non-institutional buyers (NII) category recorded a subscription of 6.89 times. However, the qualified institutional buyers (QIB) category had zero subscriptions.
The Barflex Polyfilms IPO is a book-built issue with a total size of ₹39.42 crores, comprising a fresh issue of 20.53 lakh shares worth ₹12.32 crores and an offer for sale (OFS) of 45.17 lakh shares valued at ₹27.10 crores. The subscription period for the IPO runs from January 10, 2025, to January 15, 2025, with allotment finalization scheduled for January 16, 2025, and a tentative listing date of January 20, 2025, on the NSE SME platform. The price band is set between ₹57 and ₹60 per share, with a minimum lot size of 2,000 shares. Retail investors are required to make a minimum investment of ₹1,20,000, while high net-worth individuals (HNI) must invest a minimum of ₹2,40,000, equivalent to 2 lots or 4,000 shares.
The company plans to utilize the net proceeds to
GMP Details: According to Livemint, the latest Grey Market Premium (GMP) for the Barflex Polyfilms SME IPO stands at ₹10 as of January 14, 2025. Considering the price band of ₹60, the estimated listing price is projected to be ₹70 per share with a gain of 16.67%.
Note: The Grey Market Premium (GMP) is not an official price and is based on market speculation.
Founded in June 2012, Sat Kartar Shopping Limited specializes in Ayurveda-based healthcare, providing natural wellness solutions for both therapeutic and lifestyle needs. The company is dedicated to promoting healthier living through its diverse range of holistic products, which are rooted in traditional Ayurvedic practices.
Sat Kartar Shopping Limited offers its products through multiple sales channels, including its own website, popular e-commerce platforms, television marketing, and digital advertising on Google and Meta platforms. The company aims to integrate traditional Ayurvedic practices with modern consumer needs, offering a variety of products designed to promote both therapeutic and preventive health.
In addition to its core Ayurvedic product line, Sat Kartar Shopping Limited prioritizes customer satisfaction by providing personalized wellness solutions and educating consumers about the benefits of holistic health.
(January 14, 2025, 12:24:59 PM)
The Sat Kartar Shopping IPO received a total subscription of 86.53 times as of January 14, 2025 (Day 3). The retail investor category was subscribed 114.66 times. The non-institutional investors (NII) category followed with a subscription of 111.38 times. The Qualified Institutional Buyers (QIB) was subscribed 20.23 times. Anchor investors and market makers each subscribed 1 time.
The Sat Kartar Shopping IPO is a book-built issue with a total size of ₹33.80 crores, consisting entirely of a fresh issue of 41.73 lakh shares. The subscription period for the IPO runs from January 10, 2025, to January 14, 2025. The allotment of shares is scheduled to be finalized on Wednesday, January 15, 2025, with the tentative listing date set for Friday, January 17, 2025, on the NSE SME platform. The IPO is priced within a range of ₹77 to ₹81 per share, and the minimum application size is 1,600 shares. Retail investors are required to make a minimum investment of ₹1,29,600, while high net-worth individuals (HNI) must invest at least ₹2,59,200, equivalent to 2 lots or 3,200 shares.
The net proceeds from the Fresh Issue are intended to be utilized for the following:
GMP Details: As per Live Mint, the Grey Market Premium (GMP) for the Sat Kartar Shopping SME IPO stands at ₹30. With a price band of ₹81.00, the estimated listing price for the IPO is ₹111 (calculated as the cap price plus today’s GMP), with a gain of 37.04%.
Note: The Grey Market Premium (GMP) is not an official price and is based on market speculation.
Disclaimer: Investing in SME IPOs involves a high degree of risk. Such investments may be suitable only for investors with a high-risk tolerance and the ability to bear potential losses. Perform thorough due diligence and consult a financial advisor before investing. Invest wisely and at your own discretion.
Disclaimer: The GMP (Grey Market Premium) price is unauthenticated market-related news and has no discernible basis. The same quoted above is as per news that appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade or deal in the grey market nor do we recommend or endorse trading in the grey market.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here